Coagulopathy of Acute Sepsis

Seminars in Thrombosis and Hemostasis

Volumn 41, Issue 6, 2015, Pages 650-658

  Semeraro, Nicola ^a   Ammollo, Concetta T ^a   Semeraro, Fabrizio ^a   Colucci, Mario ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

coagulation; fibrinolysis; infection; microvascular thrombosis; neutrophil extracellular traps

Indexed keywords

DNA; HISTONE; PROCOAGULANT; THROMBOPLASTIN; AUTACOID; PROTEIN C;

ACUTE SEPSIS; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DOWN REGULATION; FIBRINOLYSIS; GENE REPRESSION; HUMAN; MULTICENTER STUDY (TOPIC); NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; BLOOD; COMPLICATION; DISEASE MODEL; DISSEMINATED INTRAVASCULAR COAGULATION; ENDOTOXEMIA; EXTRACELLULAR TRAP; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MONOCYTE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOPHILIA; THROMBOTIC MICROANGIOPATHIES; VASCULAR ENDOTHELIUM;

ANIMALS; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; ENDOTHELIUM, VASCULAR; ENDOTOXEMIA; EXTRACELLULAR TRAPS; FIBRINOLYSIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; MODELS, BIOLOGICAL; MONOCYTES; MULTIPLE ORGAN FAILURE; NEUTROPHILS; PROTEIN C; SEPSIS; THROMBOPHILIA; THROMBOPLASTIN; THROMBOTIC MICROANGIOPATHIES;

EID: 84941802867     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0035-1556730     Document Type: Article

References (82)

1. Levi M., Schultz M., van der Poll T. Disseminated intravascular coagulation in infectious disease. Semin Thromb Hemost: 2010; 36 4 367 377
2. Semeraro N., Ammollo C. T., Semeraro F., Colucci M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis: 2010; 2 3 e2010024
3. Smeeth L., Cook C., Thomas S., Hall A. J., Hubbard R., Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet: 2006; 367 9516 1075 1079
4. Alikhan R., Spyropoulos A. C. Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease. Am J Med: 2008; 121 11 935 942
5. Wang H., Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med: 2008; 26 6 711 715
6. Levi M., Schultz M., van der Poll T. Sepsis and thrombosis. Semin Thromb Hemost: 2013; 39 5 559 566
7. Levi M., van der Poll T., Schultz M. Infection and inflammation as risk factors for thrombosis and atherosclerosis. Semin Thromb Hemost: 2012; 38 5 506 514
8. Rittirsch D., Flierl M. A., Ward P. A. Harmful molecular mechanisms in sepsis. Nat Rev Immunol: 2008; 8 10 776 787
9. Monroe D. M., Key N. S. The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost: 2007; 5 6 1097 1105
10. Rezaie A. R. Protease-activated receptor signalling by coagulation proteases in endothelial cells. Thromb Haemost: 2014; 112 5 876 882
11. Xu J., Zhang X., Pelayo R., et al. Extracellular histones are major mediators of death in sepsis. Nat Med: 2009; 15 11 1318 1321
12. Martinod K., Wagner D. D. Thrombosis: tangled up in NETs. Blood: 2014; 123 18 2768 2776
13. Pawlinski R., Mackman N. Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res: 2010; 125 01 S70 S73
14. Gando S., Nanzaki S., Sasaki S., Kemmotsu O. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost: 1998; 79 6 1111 1115
15. Osterud B., Bjorklid E. Sources of tissue factor. Semin Thromb Hemost: 2006; 32 1 11 23
16. Maugeri N., Brambilla M., Camera M., et al. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost: 2006; 4 6 1323 1330
17. Camera M., Frigerio M., Toschi V., et al. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs. Arterioscler Thromb Vasc Biol: 2003; 23 9 1690 1696
18. Panes O., Matus V., Sáez C. G., Quiroga T., Pereira J., Mezzano D. Human platelets synthesize and express functional tissue factor. Blood: 2007; 109 12 5242 5250
19. Osterud B. Tissue factor expression in blood cells. Thromb Res: 2010; 125 01 S31 S34
20. Semeraro N., Colucci M. Tissue factor in health and disease. Thromb Haemost: 1997; 78 1 759 764
21. Pawlinski R., Wang J. G., Owens A. P. III., et al. Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood: 2010; 116 5 806 814
22. Franco R. F., de Jonge E., Dekkers P. E., et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood: 2000; 96 2 554 559
23. Aras O., Shet A., Bach R. R., et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood: 2004; 103 12 4545 4553
24. Wang J. G., Manly D., Kirchhofer D., Pawlinski R., Mackman N. Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost: 2009; 7 7 1092 1098
25. van Hinsbergh V. W. Endothelium-Role in regulation of coagulation and inflammation. Semin Immunopathol: 2012; 34 1 93 106
26. Collier M. E., Mah P. M., Xiao Y., Maraveyas A., Ettelaie C. Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity. Thromb Haemost: 2013; 110 5 966 976
27. Rangarajan S., Kessler C., Aledort L. The clinical implications of ADAMTS13 function: the perspectives of haemostaseologists. Thromb Res: 2013; 132 4 403 407
28. Claus R. A., Bockmeyer C. L., Budde U., et al. Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thromb Haemost: 2009; 101 2 239 247
29. Rondina M. T., Schwertz H., Harris E. S., et al. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost: 2011; 9 4 748 758
30. Björkqvist J., Nickel K. F., Stavrou E., Renné T. In vivo activation and functions of the protease factor XII. Thromb Haemost: 2014; 112 5 868 875
31. van der Poll T., de Jonge E., Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost: 2001; 27 6 639 651
32. Silasi-Mansat R., Zhu H., Popescu N. I., et al. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood: 2010; 116 6 1002 1010
33. Semeraro N., Colucci M. Endothelial cell perturbation and disseminated intravascular coagulation. In: ten Cate H., Levi M., eds. Molecular Mechanisms of Disseminated Intravascular Coagulation. Georgetown Landes Bioscience: 2003; 156 190
34. Esmon C. T. Inflammation and thrombosis. J Thromb Haemost: 2003; 1 7 1343 1348
35. Faust S. N., Levin M., Harrison O. B., et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med: 2001; 345 6 408 416
36. Macias W. L., Nelson D. R. Severe protein C deficiency predicts early death in severe sepsis. Crit Care Med: 2004; 32 (5, Suppl): S223 S228
37. Liaw P. C., Esmon C. T., Kahnamoui K., et al. Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood: 2004; 104 13 3958 3964
38. Mosnier L. O., Zlokovic B. V., Griffin J. H. The cytoprotective protein C pathway. Blood: 2007; 109 8 3161 3172
39. Tang H., Ivanciu L., Popescu N., et al. Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor. Am J Pathol: 2007; 171 3 1066 1077
40. Gando S. Role of fibrinolysis in sepsis. Semin Thromb Hemost: 2013; 39 4 392 399
41. Semeraro N., Ammollo C. T., Semeraro F., Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res: 2012; 129 3 290 295
42. Wolberg A. S. Thrombin generation and fibrin clot structure. Blood Rev: 2007; 21 3 131 142
43. Mosnier L. O., Bouma B. N. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis. Arterioscler Thromb Vasc Biol: 2006; 26 11 2445 2453
44. Campbell R. A., Overmyer K. A., Selzman C. H., Sheridan B. C., Wolberg A. S. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood: 2009; 114 23 4886 4896
45. Mutch N. J., Engel R., Uitte de Willige S., Philippou H., Ariëns R. A. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood: 2010; 115 19 3980 3988
46. Carrieri C., Galasso R., Semeraro F., Ammollo C. T., Semeraro N., Colucci M. The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood. J Thromb Haemost: 2011; 9 1 154 162
47. Semeraro F., Ammollo C. T., Semeraro N., Colucci M. Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins. Haematologica: 2009; 94 6 819 826
48. Emonts M., de Bruijne E. L., Guimarães A. H., et al. Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children. J Thromb Haemost: 2008; 6 2 268 276
49. Brinkmann V., Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol: 2012; 198 5 773 783
50. Clark S. R., Ma A. C., Tavener S. A., et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med: 2007; 13 4 463 469
51. Jahr S., Hentze H., Englisch S., et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res: 2001; 61 4 1659 1665
52. Lapponi M. J., Carestia A., Landoni V. I., et al. Regulation of neutrophil extracellular trap formation by anti-inflammatory drugs. J Pharmacol Exp Ther: 2013; 345 3 430 437
53. Fuchs T. A., Brill A., Duerschmied D., et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A: 2010; 107 36 15880 15885
54. Kambas K., Mitroulis I., Apostolidou E., et al. Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS ONE: 2012; 7 9 e45427
55. Carestia A., Rivadeneyra L., Romaniuk M. A., Fondevila C., Negrotto S., Schattner M. Functional responses and molecular mechanisms involved in histone-mediated platelet activation. Thromb Haemost: 2013; 110 5 1035 1045
56. Semeraro F., Ammollo C. T., Esmon N. L., Esmon C. T. Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells. J Thromb Haemost: 2014; 12 10 1697 1702
57. Semeraro F., Ammollo C. T., Morrissey J. H., et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood: 2011; 118 7 1952 1961
58. Ammollo C. T., Semeraro F., Xu J., Esmon N. L., Esmon C. T. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost: 2011; 9 9 1795 1803
59. Wildhagen K. C., García de Frutos P., Reutelingsperger C. P., et al. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood: 2014; 123 7 1098 1101
60. Kannemeier C., Shibamiya A., Nakazawa F., et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A: 2007; 104 15 6388 6393
61. Faraday N., Schunke K., Saleem S., et al. Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils. PLoS ONE: 2013; 8 8 e71447
62. Engelmann B., Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol: 2013; 13 1 34 45
63. Arai Y., Yamashita K., Mizugishi K., et al. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation. Biol Blood Marrow Transplant: 2013; 19 12 1683 1689
64. Sunden-Cullberg J., Norrby-Teglund A., Treutiger C. J. The role of high mobility group box-1 protein in severe sepsis. Curr Opin Infect Dis: 2006; 19 3 231 236
65. Ito T., Kawahara K., Nakamura T., et al. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost: 2007; 5 1 109 116
66. Lv B., Wang H., Tang Y., Fan Z., Xiao X., Chen F. High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1. Thromb Haemost: 2009; 102 2 352 359
67. Maugeri N., Campana L., Gavina M., et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost: 2014; 12 12 2074 2088
68. Hotchkiss R. S., Nicholson D. W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol: 2006; 6 11 813 822
69. Zeerleder S., Zwart B., Wuillemin W. A., et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med: 2003; 31 7 1947 1951
70. Ekaney M. L., Otto G. P., Sossdorf M., et al. Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit Care: 2014; 18 5 543
71. Rhodes A., Wort S. J., Thomas H., Collinson P., Bennett E. D. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care: 2006; 10 2 R60
72. Levi M., Meijers J. C. DIC: which laboratory tests are most useful. Blood Rev: 2011; 25 1 33 37
73. Page A. V., Liles W. C. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence: 2013; 4 6 507 516
74. Chen Q., Ye L., Jin Y., et al. Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients. Int J Infect Dis: 2012; 16 7 e558 e564
75. Hatada T., Wada H., Nobori T., et al. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost: 2005; 94 5 975 979
76. Ranieri V. M., Thompson B. T., Barie P. S., et al. PROWESS-SHOCK Study Group. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med: 2012; 366 22 2055 2064
77. Iskander K. N., Osuchowski M. F., Stearns-Kurosawa D. J., et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev: 2013; 93 3 1247 1288
78. Iba T., Gando S., Thachil J. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan. J Thromb Haemost: 2014; 12 7 1010 1019
79. Nakahara M., Ito T., Kawahara K., et al. Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism. PLoS ONE: 2013; 8 9 e75961
80. Ito T., Kawahara K., Okamoto K., et al. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. Arterioscler Thromb Vasc Biol: 2008; 28 10 1825 1830
81. Vlahos R., Stambas J., Bozinovski S., Broughton B. R., Drummond G. R., Selemidis S. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog: 2011; 7 2 e1001271
82. Jiménez-Alcázar M., Napirei M., Panda R., et al. Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies. J Thromb Haemost: 2015; 13 5 732 742